CONMED Corporation (CNMD) - Cash Flow Conversion Efficiency
Based on the latest financial reports, CONMED Corporation (CNMD) has a cash flow conversion efficiency ratio of 0.045x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($46.34 Million) by net assets ($1.03 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
CONMED Corporation - Cash Flow Conversion Efficiency Trend (1990–2025)
This chart illustrates how CONMED Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read CNMD current and long-term liabilities for a breakdown of total debt and financial obligations.
CONMED Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of CONMED Corporation ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Nokian Renkaat Oyj
HE:TYRES
|
0.015x |
|
Carabao Group Public Company Limited
BK:CBG
|
0.036x |
|
Shanghai Zhongzhou Special Alloy Materials Co. Ltd.
SHE:300963
|
-0.046x |
|
Willdan Group Inc
NASDAQ:WLDN
|
0.043x |
|
Day One Biopharmaceuticals Inc
NASDAQ:DAWN
|
-0.013x |
|
Energizer Holdings Inc
NYSE:ENR
|
1.058x |
|
Intellect Design Arena Limited
NSE:INTELLECT
|
0.027x |
|
SILEX Systems Ltd
AU:SLX
|
0.027x |
Annual Cash Flow Conversion Efficiency for CONMED Corporation (1990–2025)
The table below shows the annual cash flow conversion efficiency of CONMED Corporation from 1990 to 2025. For the full company profile with market capitalisation and key ratios, see CONMED Corporation (CNMD) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $1.03 Billion | $170.69 Million | 0.165x | -4.74% |
| 2024-12-31 | $962.68 Million | $166.97 Million | 0.173x | +15.43% |
| 2023-12-31 | $834.22 Million | $125.35 Million | 0.150x | +235.75% |
| 2022-12-31 | $745.54 Million | $33.37 Million | 0.045x | -68.55% |
| 2021-12-31 | $785.43 Million | $111.77 Million | 0.142x | +56.36% |
| 2020-12-31 | $709.04 Million | $64.53 Million | 0.091x | -32.03% |
| 2019-12-31 | $710.47 Million | $95.13 Million | 0.134x | +18.71% |
| 2018-12-31 | $662.27 Million | $74.70 Million | 0.113x | +8.63% |
| 2017-12-31 | $631.43 Million | $65.57 Million | 0.104x | +57.72% |
| 2016-12-31 | $580.58 Million | $38.22 Million | 0.066x | -19.87% |
| 2015-12-31 | $585.07 Million | $48.07 Million | 0.082x | -26.72% |
| 2014-12-31 | $581.30 Million | $65.18 Million | 0.112x | -16.02% |
| 2013-12-31 | $606.32 Million | $80.95 Million | 0.134x | -14.87% |
| 2012-12-31 | $607.00 Million | $95.20 Million | 0.157x | -12.73% |
| 2011-12-31 | $573.07 Million | $102.99 Million | 0.180x | +175.65% |
| 2010-12-31 | $586.56 Million | $38.24 Million | 0.065x | +50.18% |
| 2009-12-31 | $576.51 Million | $25.03 Million | 0.043x | -62.25% |
| 2008-12-31 | $531.73 Million | $61.15 Million | 0.115x | -11.87% |
| 2007-12-31 | $505.00 Million | $65.89 Million | 0.130x | -11.02% |
| 2006-12-31 | $440.35 Million | $64.57 Million | 0.147x | +56.54% |
| 2005-12-31 | $453.01 Million | $42.43 Million | 0.094x | -43.93% |
| 2004-12-31 | $447.98 Million | $74.84 Million | 0.167x | +24.84% |
| 2003-12-31 | $433.49 Million | $58.01 Million | 0.134x | +15.27% |
| 2002-12-31 | $386.94 Million | $44.92 Million | 0.116x | -57.32% |
| 2001-12-31 | $283.63 Million | $77.15 Million | 0.272x | +74.48% |
| 2000-12-31 | $230.60 Million | $35.95 Million | 0.156x | -10.97% |
| 1999-12-31 | $211.30 Million | $37.00 Million | 0.175x | +51.93% |
| 1998-12-31 | $182.20 Million | $21.00 Million | 0.115x | -41.03% |
| 1997-12-31 | $162.70 Million | $31.80 Million | 0.195x | +19.69% |
| 1996-12-31 | $158.60 Million | $25.90 Million | 0.163x | +140.15% |
| 1995-12-31 | $75.00 Million | $5.10 Million | 0.068x | -64.69% |
| 1994-12-31 | $43.10 Million | $8.30 Million | 0.193x | +26.69% |
| 1993-12-31 | $37.50 Million | $5.70 Million | 0.152x | +63.40% |
| 1992-12-31 | $38.70 Million | $3.60 Million | 0.093x | +125.91% |
| 1991-12-31 | $34.00 Million | $1.40 Million | 0.041x | -89.86% |
| 1990-12-31 | $12.80 Million | $5.20 Million | 0.406x | -- |
About CONMED Corporation
CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation an… Read more